🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Aytu BioPharma, Inc. (AYTU)
NASDAQ: AYTU · Real-Time Price · USD
2.660
0.00 (0.00%)
At close: Nov 20, 2026, 4:00 PM EST
2.650
-0.010 (-0.38%)
After-hours: Nov 20, 2026, 7:55 PM EST

Aytu BioPharma Stock Forecast

Stock Price Forecast

According to 3 analysts polled by S&P Global, Aytu BioPharma stock has a consensus rating of "Buy" and an average price target of $8.85. The average 1-year stock price forecast is 232.71% higher than the current stock price, while the lowest is $2.70 (+1.50%) and the highest is $15 (+463.91%).

Price Target: $8.85 (+232.71%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$2.70$8.85$8.85$15
Change+1.50%+232.71%+232.71%+463.91%

Analyst Ratings

The average analyst rating for Aytu BioPharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Sep '26Oct '26Nov '26
Strong Buy222221
Buy111110
Hold000002
Sell000000
Strong Sell000000
Total333333

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Maxim Group
Maxim Group
Hold
Downgrades
$7
HoldDowngrades$7+163.16%Nov 17, 2026
Lake Street
Lake Street
Hold
Downgrades
$7 → $2.7
HoldDowngrades$7 → $2.7+1.50%Nov 17, 2026
Ascendiant
Ascendiant
Buy
Maintains
$15 → $15
BuyMaintains$15 → $15+463.91%Sep 29, 2026

Financial Forecast

Revenue This Year
70.90M
from 57.57M
Increased by 23.15%
Revenue Next Year
86.91M
from 70.90M
Increased by 22.58%
EPS This Year
-0.37
from -0.83
EPS Next Year
0.16
from -0.37
Fiscal YearFY 2022FY 2023FY 2024FY 2025FY 2026FY 2027E
Period EndingJun 30, 2022Jun 30, 2023Jun 30, 2024Jun 30, 2025Jun 30, 2026Jun 30, 2027
Revenue
96.67M73.80M65.18M66.38M57.57M70.90M
Revenue Growth
47.29%-23.66%-11.68%1.84%-13.28%23.15%
Gross Profit
50.28M52.23M49.05M45.83M36.82M45.14M
Gross Margin
52.02%70.77%75.26%69.04%63.95%63.67%
Operating Income
-38.10M-5.21M565.00K2.54M-8.32M-9.66M
Net Income
-108.78M-17.05M-15.84M-13.56M-14.25M-11.92M
EPS
-----0.83-0.37
Free Cash Flow
-----9.90M
No. Analysts
-----1
EPS and Forward PE are based on non-GAAP adjusted numbers.

Revenue Forecast

Revenue202720282029
High70.9M
Avg70.9M
Low70.9M

Revenue Growth

Revenue Growth202720282029
High
23.2%
Avg
23.2%
Low
23.2%

EPS Forecast

EPS202720282029
High-0.16
Avg-0.37
Low-0.57

EPS Growth

EPS Growth202720282029
High-
Avg-
Low-